Proteomic analyses of seasonal human respiratory viruses unravel changes related to antiviral, inflammatory, and cell death pathways Authors: Júlia A Cerato, M Immanuel R Madlangsakay, Rene P Zahedi, Barbara N Porto, Kevin M Coombs Published: 2026 ABSTRACT SummaryNewly emerging and re-emerging viruses are of significant global concern. Several viruses cause significant respiratory distress, including human coronaviruses (hCoVs), influenza A viruses (IAVs), and respiratory syncytial virus (RSV). Viruses usurp and modify host cellular processes to successfully replicate. We used quantitative label-free mass spectrometry-based proteomic analyses of transformed human lung A549 cells infected with representative seasonal hCoV, IAV, and RSV at 24 h post-infection to delineate comparative virus-induced host cell alterations. Numerous proteins involved in lipid metabolism, molecular transport, cell death and survival, and inflammatory responses were dysregulated. RSV induced a more profound response in cellular protein quantities than either CoV or IAV. The most significantly affected proteins were enzymes, ion channels, kinases, transcription regulators, and transmembrane receptors. Many canonical pathways also were differentially affected by each virus. The altered expression of proteins and pathways may provide insights into future therapeutic interventions for these viral infections.Keywords: seasonal human coronavirus, influenza virus, respiratory syncytial virus, proteomic analyses, antiviral pathways, inflammatory pathways, cell death pathways Introduction Viruses are obligate intracellular parasites that depend upon host processes for their replication. During their replication, viruses induce profound changes in the host cell’s protein repertoire (proteome). Viruses remain responsible for millions of deaths annually. In particular, the 1918 influenza is estimated to have resulted in 50–100 million deaths.1,2 While considerably milder, the 2009 pandemic, caused by an influenza A virus (IAV) designated pdm09, is believed to have caused approximately 285,000 deaths in the first year (https://www.mayoclinic.org/diseases-conditions/swine-flu/symptoms-causes/syc-20378103). The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has killed more than 7,000,000 people so far. Human coronavirus OC43 (CoV OC43) circulates in the human population, causing mild to moderate upper respiratory infection with a seasonal pattern. However, CoV OC43 infection can also progress to severe disease, including pneumonia and bronchitis, in older adults and immunocompromised individuals.3,4 Currently, there are no effective vaccines or antiviral approaches to prevent and/or treat CoV OC43 infection. Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory tract infection in infants and young children and is responsible for over 3 million hospitalizations and up to 100,000 deaths annually, worldwide.5,6 RSV infection may lead to severe consequences, especially in infants born preterm or with high-risk medical conditions, such as bronchopulmonary dysplasia, congenital heart disease, or chronic lung disease.7 Furthermore, accumulating evidence suggests an association between severe RSV disease in early life and recurrent wheezing and asthma later in life.8,9,10,11 While three RSV vaccines have been developed for the elderly and adults with high-risk conditions, and there have been important advances in prophylactic therapies for infants (e.g., extended half-life monoclonal antibodies) and a maternal RSV vaccine that aims to protect infants from birth up to 6 months of age, there are currently no RSV vaccines or effective antiviral therapies for young children. Therefore, clinical treatment of RSV infection is only supportive. Furthermore, RSV infections also lead to approximately 336,000 hospitalizations and 14,000 deaths annually.12 Rapid COVID-19 vaccine development and administration blunted the worst of that pandemic. Vaccines have been useful for ameliorating many infectious diseases, including smallpox, polio, and influenza.13,14 However, mutations that occur within viral genomes as part of natural evolution can render vaccines ineffective. Thus, there is growing interest in understanding and exploiting cellular processes that viruses require and that can be modulated to protect against these pathogenic organisms. Previous studies have identified proteomic alterations induced by numerous viruses (i.e., Bojkova et al.,15 Chongsatja et al.,16 Coombs et al.,17 Dhingra et al.,18 Hekman et al.,19 Mannova et al.,20 Munday et al.,21 and Skiba et al.22). Most of these studies usually focus on a single pathogen. Some studies have compared proteomic responses of multiple strains of similar viruses within the same family. We used quantitative multiplexed isobaric tags for relative and absolute quantification (ITRAQ)-based mass spectrometry to compare four different IAVs of varying pathogenicity,23 aptamer profiling to compare five different IAVs of varying pathogenicity,24 and van Diepen and colleagues used 2-dimensional difference in gel electrophoresis (2D-DIGE) to compare four different paramyxoviruses.25 In the present study, we performed comparative simultaneous analyses to better compare cellular proteomic alterations induced by representative CL-2 level seasonal CoV OC43, IAV pdm09, and RSV strain A2. We chose A549 as model human lung cells because we and others have shown that CoV OC43,26,27,28 IAV pdm09,24,29,30 and RSV A231,32,33 can infect and affect these cells. RSV A2 appeared to induce a far more robust cellular response than did the other two viruses, with major dysregulated processes that included the mitochondrial functions, electron transport and oxidative phosphorylation, neutrophil degranulation, cytokine signaling, and cell cycle and anti-inflammatory responses. However, several processes, such as cell death signaling, integrin and FAK signaling, rRNA and capped intron-containing pre-RNA processing, and mitotic prophase, were differentially affected by the three viruses. Results CoV OC43, IAV pdm09, and RSV A2 all induced profound alterations in the A549 cellular proteome To better understand pathogenic mechanisms of these three common respiratory viruses, we compared the cellular proteomes of CoV-, IAV-, and RSV-infected A549 cells by quantitative mass spectrometry at 24 hours post-infection (hpi) to those of mock, non-infected cells. Cells were infected with each virus at multiplicities of infection (MOIs) of three plaque-forming units (PFUs) per cell, which, by Poisson calculations, should result in >90% of cells being infected. Time-dependent increases in immunofluorescence demonstrated that all three viruses successfully infected the A549 cells and that the vast majority demonstrated infection by 24 hpi under these conditions (Figure 1A). We applied numerous p value and fold-change cut-offs, with and without Benjamini-Hochberg multiple testing correction, to assess protein quantity changes relative to non-infected mock (Table 1). A549 peptide and protein characteristics altered by human coronavirus OC43, influenza virus pdm09, and respiratory syncytial virus (A) Immunofluorescent microscopy of CoV OC43- (top row), IAV pdm09- (middle row), and RSV A2- (bottom row) infected A549 cells, either mock-infected (leftmost) or infected for indicated periods of time at MOI = 3. “0-time” represents the end of the 2-h-long adsorption period. The secondary antibody used for OC43 and pdm09 was Alexa Fluor 488-tagged and the secondary antibody for RSV was Alexa Fluor 647-tagged. Images representative of 3 separate biological replicates. Scale bars, 500 μm. (B) Volcano plots of dysregulated proteins, with upregulated indicated with red dots and downregulated indicated with green dots. The horizontal line refers to p < 0.01 using unpaired Student’s t test. (C) Virus-virus comparisons of selected proteins, with those commonly upregulated in upper-right quadrants, those commonly downregulated in lower-left quadrants, and those differentially quantified in upper-left and lower-right. The gray-shaded box corresponds to 2-fold dysregulation. n = 3 biological replicates. Table 1Number of A549 cellular proteins affected by CoV, IAV, and RSVCov OC43IAV pdm09RSVp < 0.05p < 0.01B-Hap < 0.05p < 0.01B-Hp < 0.05p < 0.01B-HTotal proteinsOverallb8,006–––7,966–––7,988–––w/2 replicatesc7,873–––7,815–––7,823–––Fold change (FC)>1.00004,6282,4541,6092454,2812,4641,6962654,2662,5261,836291<1.00003,2451,257665513,5341,658954823,5571,7141,041110>1.25002,4681,9511,4142392,6262,1131,5712592,7512,2521,735290<0.80001,062734464421,4901,123742781,6281,247864106>1.33331,9291,6101,2212272,1931,8621,4492552,3942,0481,649287<0.7500621436296351,052826576631,16894069496>1.50009778476721541,4381,2651,0482141,7681,5951,369271<0.6667215150116194713712763466957146283>2.0000183155137661551138523604561512186<0.50002817143473523420418316752>2.50009583764254362710281255240116<0.40001176214106289807532>3.000051464324261916617015514382<0.33334221322248434221average FCd18.36–––32.16–––41.21–––# IPA networks identified–25e2514–252515–252523# IPA canonical pathways––––––––––––with Z score ≥1.97–16116170–16416538–377378115with Z score ≤ -1.97–993–20204–17176aM.C.: Benjamini-Hochberg multiple correction applied.bTotal number of A549 proteins in the dataset with indicated fold change identified with at least 2 peptides.cTotal number of A549 proteins in the dataset with indicated fold change identified with at least 2 peptides in at least 2 of 3 experimental replicates.dAverage fold-change of all proteins identified with at least 2 peptides in dataset, determined by averaging |log2| FC.eThe maximum number of IPA-identified networks under default settings is 25. Number of A549 cellular proteins affected by CoV, IAV, and RSV M.C.: Benjamini-Hochberg multiple correction applied. Total number of A549 proteins in the dataset with indicated fold change identified with at least 2 peptides. Total number of A549 proteins in the dataset with indicated fold change identified with at least 2 peptides in at least 2 of 3 experimental replicates. Average fold-change of all proteins identified with at least 2 peptides in dataset, determined by averaging |log2| FC. The maximum number of IPA-identified networks under default settings is 25. We identified a total of 156,702 unique peptides and 8,688 unique proteins, 7,959 of which were identified with two or more unique peptides and in at least two of the three biologic replicates. More than 7,800 proteins were affected by each virus (Table 1; Figure S1). 7,225 proteins were observed and measured in all 12 samples (3 each of mock, CoV, IAV, and RSV). 847 A549 proteins were significantly (p < 0.05) upregulated at least 1.5-fold by CoV OC43 infection, and 150 proteins were significantly downregulated at least 1.5-fold (to 0.6667-fold of mock). These protein values were reduced to 672 upregulated and 116 downregulated if a more stringent p value cut-off of 0.01 was applied (Table 1). The values were further reduced when Benjamini-Hochberg multiple correction stringency was applied, with 154 upregulated and 19 downregulated (Table 1). We use the term “upregulated” to indicate if the amount of measured protein was increased, which might result from increased biosynthesis, decreased turn-over, or a combination of the two processes. Similarly, we use the term “downregulated” to indicate if the amount of measured protein was decreased, which might result from decreased biosynthesis, increased turnover, or a combination of the two processes. By comparison, IAV pdm09 induced upregulation of 1,265 proteins at p < 0.05 and 1,048 proteins at p < 0.01 without Benjamini-Hochberg correction, 214 proteins after Benjamini-Hochberg correction, and downregulation of 371 proteins at p < 0.05 and 276 proteins at p < 0.01 without Benjamini-Hochberg correction, and 214 proteins after Benjamini-Hochberg correction; RSV A2 induced upregulation of 1,595 proteins at p < 0.05, 1,369 proteins at p < 0.01, and 271 proteins after multiple correction and downregulation of 571 proteins at p < 0.05, 462 proteins at p < 0.01, and 83 proteins after multiple correction (Figure 1B; Table 1). Subsequent uploading of the datasets into the Ingenuity Pathway Analysis (IPA) tool predicted correspondingly reduced numbers of affected networks as stringencies were increased (Table 1, middle and bottom). For example, at p < 0.05 and at p < 0.01 without Benjamini-Hochberg correction, the maximum default number of 25 networks were identified for all three virus infections. However, these numbers were reduced to 14, 15, and 23 for CoV OC43, IAV pdm09, and RSV A2, respectively, after Benjamini-Hochberg correction. The numbers of IPA-predicted canonical pathways also were essentially unchanged at p < 0.05 and p < 0.01 but were substantially reduced when Benjamini-Hochberg correction was applied. Despite the differences in the numbers of predicted pathways predicted to be significantly activated (Z score ≥ +1.97σ) or significantly inhibited (Z score ≤ −1.97σ), the most-activated and the most-inhibited predicted pathways were usually the same (Table S1). Neutrophil degranulation was the most-activated predicted pathway by OC43 at p < 0.05 and p < 0.01, and it was the second most-predicted activated pathway after multiple-correction (slightly behind class I MHC antigen processing). Neutrophil degranulation also was the most-activated predicted pathway by RSV A2 at all stringencies, and mitochondrial translation was the most-activated predicted pathway by IAV pdm09 at all stringencies. Mitochondrial dysfunction was the most-inhibited predicted pathway by all three viruses at most stringencies, with the exception that it was third most inhibited by OC43 under multiple-correction (with MSP-RON the most inhibited) and the sixth most inhibited by RSV under multiple correction (with major pathway of rRNA processing most inhibited). Because pathway analyses are based on groups of functionally related proteins, they may be less affected than single-protein comparisons by the loss of individual candidates after more stringent statistical filtering. We, therefore, compared pathway-level outputs obtained using both Benjamini-Hochberg corrected and less stringent uncorrected p value thresholds. As the major enriched pathways were similar under both conditions, the broader protein lists were used in subsequent exploratory analyses. Comparisons of the dysregulated proteins indicated that many were commonly affected by all three viruses (Figure 1C). For example, interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) was significantly upregulated 4.15-fold by CoV OC43, 17.8-fold by IAV pdm09, and approximately 94-fold by RSV (Tables S2 and S3). Similarly, interferon-stimulated gene 15 (ISG15) was significantly upregulated 4.55-fold by CoV OC43, 4.4-fold by IAV pdm09, and almost 52-fold by RSV and retinoic acid-inducible gene I (RIG-I) was significantly upregulated 3.8-fold by CoV OC43, 3.4-fold by IAV pdm09, and 25-fold by RSV. Some proteins also were commonly downregulated by all three viruses. For example, transcription factor 20 (TCF20) was significantly downregulated 3-fold by CoV OC43 (to 0.33 of mock), 7.65-fold by IAV pdm09, and 4-fold by RSV (Figure 1C; Tables S2, and S3) and U6 snRNA-associated Sm-like protein 1 (LSM1) was significantly downregulated 2.95-fold by CoV OC43, 2.68-fold by IAV pdm09, and 2.75-fold by RSV. A few cellular proteins were differentially affected. For example, metallothionein-1A (MT1A) was downregulated 3.25-fold by IAV pdm09 but upregulated 1.65-fold by CoV OC43 and 2.76-fold by RSV, and antithrombin-III (SERPINC1) was significantly upregulated 1.3-fold by CoV OC43 and 3.2-fold by IAV pdm09 but significantly downregulated 3.6-fold by RSV. A full listing of all measured proteins and their degree of dysregulation is presented in Table S3. Many of these differences in degree and direction of dysregulation were also reflected more globally in examining protein categories (Figure 2). For example, a significant number of cytokines were decreased in abundance in the RSV infection. Enzymes also were significantly affected by all viruses, with all viruses inducing significant increases in protein abundances, and RSV also significantly inducing decreases in protein abundances. RSV appeared to induce more profound changes than the other viruses. In addition to the aforementioned fold differences, of the 28 protein categories (14 up and 14 down), RSV induced significant differences in 13 (numbers of enzymes, ion channels, kinases, peptidases, transcription regulators, transmembrane receptors, transporters, and others were significantly more abundant, whereas cytokines, enzymes, transcription regulators, transporters, and others were significantly less abundant). Furthermore, comparisons of the overall average fold-changes induced by the three viruses suggested CoV OC43 caused an approximate 18% change, IAV pdm09 affected ∼32% alteration, and RSV triggered about a 41% change (Table 1, middle). Protein types dysregulated by CoV OC43, IAV pdm09, and RSV Proteins and their quantities were uploaded into Ingenuity Pathway Analysis (IPA). Protein types are indicated by the respective pie colors. Significances were determined by chi-square analysis and significant differences indicated in red text. n = 3 biological replicates. We noted that many of these dysregulated proteins are known to be involved in various processes associated with antiviral responses, cell death, and inflammatory pathways. Therefore, we assessed their upregulation and downregulation (Figure 3A). Virus infection effects on proteins involved in antiviral, cell death, and inflammatory pathways (A) Dot plots of identified proteins in indicated pathways. Circle colors (below the plots) represent log2 fold-changes compared with mock, and circle sizes (right) define significances using unpaired Student’s t test. (B) Western blots of indicated proteins in indicated virus infections. n = 3 biological replicates. Many of the proteins in these pathways are upregulated ∼4-fold (2 log2), as indicated by greenish colors. A small number of proteins (i.e., DEAD-box helicase [DDX]21 and DDX27 in the antiviral pathways) are downregulated by RSV but upregulated by the other viruses. Intercellular adhesion molecule 1 (ICAM1) is upregulated >16-fold (>4 log2) by CoV OC43 and by RSV but only ∼3-fold by IAV pdm09. Many of the IFIT molecules are highly upregulated by RSV but much less so by the other viruses, and chemokine C-X-C motif ligand 1 (CXCL1) in the inflammatory pathway is highly upregulated by CoV OC43, but not as greatly affected by the other viruses. Many of the proteins in the antiviral pathway are downregulated nearly 4-fold. (Figure 3A). We performed western blotting analysis to confirm changes in the expression of specific proteins involved in cell death pathways. We found that RSV induced gasdermin D (GSDMD) and apoptosis-associated speck-like protein containing a CARD (PYCARD; also known as ASC) expression, while IAV pdm09 and CoV OC43 did not. Also, both RSV and CoV OC43 triggered GSDME and mixed lineage kinase domain-like pseudokinase (MLKL) expression in A549 cells, but IAV pdm09 did not, corroborating our proteomics data (Figure 3B). These data are consistent with differential engagement of the pyroptosis and necroptosis pathway components by the various seasonal viruses. Cellular networks affected by virus infection We uploaded the datasets of proteins and their levels of expression into IPA to map cellular processes predicted to be affected by virus infection. A global overview indicated that numerous cellular processes were affected (Figure 4A) and that all viruses induced profound alterations in upregulated (orange) and downregulated (blue) disease and function processes (Figure 4B). Ingenuity Pathway Analysis global overview of dysregulated cellular processes induced by human coronavirus OC43, influenza virus pdm09, and RSV (A) IPA-generated “graphical summary of processes affected by each virus”. (B) Global overview of “diseases and functions”. Proteins and their quantities were uploaded into IPA and default settings used. n = 3 biological replicates. We also used IPA to predict cellular networks and pathways that were significantly affected by each virus. The numbers and identifications of specific virus-induced pathways were affected by the degree of stringency applied to the datasets uploaded to IPA. For example, a total of 25 networks (the maximum default identified by IPA), including connective tissue disorders, cellular development, and infectious diseases, were affected by each virus if Benjamini-Hochberg multiple correction was not applied, but only 14, 15, and 23 networks were identified in CoV OC43, IAV pdm09, and RSV infections, respectively, if Benjamini-Hochberg multiple correction was applied. CoV OC43 and RSV significantly affected networks involving antimicrobial response and infectious diseases (Figure 5), irrespective of whether Benjamini-Hochberg multiple correction was applied. When Benjamini-Hochberg multiple correction was applied, most proteins in the CoV-induced antimicrobial and infectious disease response network were upregulated by CoV OC43 whereas only two proteins (acylphosphatase-1, ACYP1) and (threonine-tRNA ligase 1, TARS1) were downregulated (Figure 5A). TARS1 also was downregulated by IAV pdm09 but ACYP1 was not significantly altered. Neither ACYP1 nor TARS1 were downregulated by RSV and fewer proteins in this network were upregulated by both IAV pdm09 and by RSV. IPA-generated antimicrobial and infectious diseases networks (A) The hCoV antimicrobial network identified under Benjamini-Hochberg stringency. (B) The same network overlaid with “open analysis” (no B-H correction). (C) The RSV infectious disease network identified under Benjamini-Hochberg stringency. (D) The same network overlaid with open analysis. Proteins and their quantities were uploaded into IPA and default network setting used. The larger images on the left in (A) and (C) depict the indicated networks affected by each virus. The smaller images on the right and large images below are overlays of the same networks as affected by the other two indicated viruses. Proteins whose quantities are significantly increased at least 1.5-fold are indicated in shades of red; proteins whose quantities are significantly decreased at least 1.5-fold are indicated in shades of green. Other proteins that make up the predicted network but are not significantly dysregulated are shown in gray. Protein types are indicated in the blue-shaded legend on the far right. n = 3 biological replicates. The top-scoring networks affected by each virus in the absence of Benjamini-Hochberg multiple correction, and corresponding overlays of the other two viruses on these networks, are depicted in Figure 6. The “cancer, lipid metabolism, and small molecule biochemistry” network was most affected by CoV OC43, with 34 proteins highlighted and an IPA score of 61. Most proteins in this network were significantly upregulated by CoV OC43, but five (including phosphoserine aminotransferase 1 [PSAT1], microtubule associated protein RP/EB family member 2 [MAPRE2], and UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 [UAP1L1]) were downregulated. IAV and RSV affected many of the same proteins in this network similarly, although PSAT1 was unaffected by both, and while CoV upregulated RAS guanine nucleotide exchange factors (RAS GEFs), both IAV and RSV downregulated these molecules. IPA-generated top-scoring networks Proteins and their quantities were uploaded into IPA and default network setting used. The larger images on the left depict the highest scoring networks affected by each virus. The smaller images on the right are overlays of the same networks as affected by the other two indicated viruses. Proteins whose quantities are significantly increased at least 1.5-fold are indicated in shades of red; proteins whose quantities are significantly decreased at least 1.5-fold are indicated in shades of green. Other proteins that make up the predicted network but are not significantly dysregulated are shown in gray. Protein types are indicated in the blue-shaded legend on the far right. n = 3 biological replicates. IAV affected the “cellular response to therapeutics, gene expression, and RNA post-transcriptional modification” network the most, with 33 proteins highlighted and an IPA score of 58 (Figure 6). Most of the identified proteins were significantly upregulated, and only two: arsenic +3 oxidation state methyltransferase (AS3MT) and Chromobox 6 (CBX6) were downregulated. CoV OC43 had little effect on this network, with most proteins not significantly dysregulated. Many more proteins in this network were downregulated by RSV. All viruses downregulated AS3MT. RSV affected the “cell death and survival, cell-cell signaling and interaction, and RNA post-transcriptional modification” network the most, with 34 proteins highlighted and an IPA score of 56. Most proteins in this network were significantly downregulated, with only five (including nicotinamide mononucleotide adenylyltransferase 1 [NMNAT1] and centromere protein V [CENPV]) upregulated. The histone H2A family (H2AF) and histone variant MACROH2A2 were upregulated by all three viruses. CoV OC43 had little effect on most proteins in this network and IAV pdm09 upregulated many proteins in this network (Figure 6). Cellular canonical pathways affected by virus infection There also were differences in cellular pathways predicted to be affected. CoV OC43 induced significant predicted inhibition (Z score ≤ −2) of 10 canonical pathways and significant predicted activation (Z score ≥ +2) of 124 canonical pathways. IAV pdm09 induced significant predicted inhibition (Z score ≤ −2) of 22 canonical pathways and significant predicted activation (Z score ≥ +2) of 120 canonical pathways, and RSV induced significant predicted inhibition (Z score ≤ -2) of 15 canonical pathways and significant predicted activation (Z score ≥ +2) of 321 canonical pathways. Some of the most significantly predicted activated (Figure 7A) and all predicted significantly inhibited (Figure 7B) pathways are depicted. Canonical pathways regulated by CoV OC43, IAV pdm09, and RSV infection Canonical pathways (A) activated and (B) inhibited by CoV OC43, IAV pdm09, and RSV infection. Proteins and their quantities were uploaded into IPA and default canonical pathway settings used. Predicted, activated (positive Z score), and inhibited (negative Z score) were returned and sorted in Microsoft Excel. Circle sizes correspond to numbers of proteins assigned to each pathway and are color-coded by virus, as indicated. The solid vertical black line at 0 separates positive values from negative values, and the vertical red lines indicate Z score cut-offs of −2.0 and +2.0. n = 3 biological replicates. Because of the much larger number of predicted significantly activated canonical pathways, we focused on 50 of the most activated, and because of overlap between pathways activated by each virus, this resulted in the top 20 each of those affected by CoV OC43 and IAV pdm09 and the top 38 of those affected by RSV infection. The most highly activated pathway was “mitochondrial translation” with a Z score of 5.099 (26 proteins identified) for CoV OC43, a Z score of 9.055 (82 proteins identified) for IAV pdm09, and a Z score of 4.472 (20 proteins identified) for RSV A2. Other highly activated canonical pathways included “neutrophil degranulation,” “electron transport and ATP synthesis,” “oxidative phosphorylation,” and “neutrophil extracellular trap signaling”. The most highly inhibited canonical pathway was “mitochondrial dysfunction,” with respective scores of: CoV OC43 (Z score −4.081; 50 proteins), IAV pdm09 (Z score −7.54; 78 proteins), and RSV (Z score −6.96; 91 proteins). Other highly inhibited pathways included “granzyme A signaling,” RHOGDI signaling,” and “sirtuin signaling”. Three canonical pathways were activated/inhibited significantly differently by the various viruses. The “pitotic prophase” canonical pathway was predicted to be significantly inhibited (Z score = −2) by CoV OC43, slightly activated (Z score = 0.7) by IAV pdm09, and significantly activated (Z score = 3.84) by RSV, the “processing of capped intron-containing pre-mRNA” canonical pathway was predicted to be activated (Z score = 3.3) by CoV OC43, inhibited (Z score = −2.73) by IAV pdm09, and unaffected by RSV, and the “major pathway of rRNA processing in the nucleolus” canonical pathway was predicted to be significantly activated (Z score = 3.46) by IAV pdm09 and significantly inhibited (Z score = −6.03) by RSV. Insufficient numbers of proteins in this pathway were affected by CoV OC43 for IPA to generate a prediction. The Ingenuity Pathway Artificial Intelligence Plug-in summarized the wealth of analyzed data by indicating that overall CoV OC43 infection affected an integrated network of interferon-mediated antiviral defense and inflammatory immune activation, consisting of type I and type III interferon signaling, pro-inflammatory cytokine coordination and leukocyte activation, pattern recognition receptors and viral sensing, and integration of immune signaling with metabolic pathways and regulatory feedback and pathway modulations. Overall, IAV pdm09 infection affected an integrated network of cellular energy metabolism, oxidative stress protection, and growth signaling, consisting of regulation of cellular energy production, control of mitochondrial respiration and oxygen utilization, antioxidant defense and reactive oxygen species regulation, insulin/IGF1 and growth factor signaling integration, and coordination of molecular transport and metabolite flux. Overall, RSV infection affected coordinated regulation of innate and adaptive immune responses to viral infection, consisting of integrated interferon-driven antiviral response, amplification of innate immune signaling pathways, control by negative regulators and immune homeostasis, immunometabolic reprogramming during immune activation, and crosstalk between anti-viral, antimicrobial, and inflammatory pathways. Discussion Non-biased quantitative mass spectrometry has been useful in identifying alterations induced in cellular proteins after infection by numerous viruses, including HIV,34 influenza viruses,17,35,36 herpesvirus,37,38 and Zika virus.39,40,41 Here, we applied this technique and measured more than 8,300 cellular proteins, many of which were differentially dysregulated by three different CL-2 respiratory viruses. We use the term “dysregulated” to refer to proteins whose quantities change compared with those in non-infected mock cells, recognizing that alterations in protein quantities may result from increased or reduced protein synthesis and/or increased or reduced protein turnover. Some of the proteins considered significantly dysregulated by either t test or Z score analysis were only altered in quantity by as little as 5%. For example, 3,711 proteins were significantly dysregulated by CoV OC43 (2,454 > 1.00-fold and 1,257 < 1.000-fold, p < 0.05; Table 1) but only 2,685 (1,951 up and 734 down) were dysregulated >25%. Numbers of dysregulated proteins were smaller at a greater p value stringency of 0.01. Numerous studies have used various fold-change cut-offs ranging from as low as 5% to as much as 2-fold or more. We chose cut-offs of ±1.5-fold change and p value <0.05 for IPA, which resulted in 997 CoV OC43-affected A549 proteins, 1,636 IAV pdm09-affected proteins, and 2,166 RSV-affected proteins to have reasonable numbers to analyze while still maintaining some stringency. We also applied fold-change cut-offs of ±1.333, ±1.667, and ±2.0 and p values <0.01 and uploaded those resulting datasets into IPA for analysis. While the numbers of resultant analyzable proteins were altered, many of the same networks and pathways were identified at higher and lower stringency. A primary purpose for performing these studies was to compare cellular proteins, pathways, and processes that are similarly or differentially affected by these three CL-2-level seasonal respiratory viruses. Many proteins were similarly affected by all three viruses but to different extents. For example, IFIT1 was significantly upregulated by all; 4.15-fold by CoV OC43, 17.83-fold by IAV pdm09, and 93.98-fold by RSV A2 compared with mock. ISG15 also was upregulated by all; 4.55-fold by CoV OC43, 4.39-fold by pdm09, and 51.72-fold by RSV. In total, 20 cellular proteins were significantly upregulated >2.0-fold by all viruses. No cellular proteins were downregulated >2.0-fold by all three viruses, but 17 proteins were downregulated >1.5-fold by all three. These included glypican-1 (GPC1), which was downregulated 1.98-fold by CoV OC43, 1.66-fold by IAV pdm09, and 2.74-fold by RSV, and UAP1L1, which was downregulated 1.8-fold by CoV OC43, 1.85-fold by pdm09, and 4.17-fold by RSV. Several proteins were similarly affected by both CoV OC43 and RSV, but not by IAV pdm09. For example, neutrophil gelatinase-associated lipocalin (LCN2) was significantly upregulated 18.6-fold by CoV OC43 and 23.8-fold by RSV but was affected by IAV pdm09 only 1.06-fold higher than mock, and CXCL1 was significantly upregulated 31.8-fold by CoV OC43 and 10.8-fold by RSV, but was reduced only 1.07-fold by IAV pdm09. Conversely, a few proteins were significantly dysregulated only by IAV pdm09. These included hepatocyte growth factor activator (HGFAC), which was significantly upregulated 3.05-fold by IAV pdm09 (p = 4.4 × 10-4), but not significantly dysregulated by either CoV OC43 (1.2-fold increase) or RSV (1.18-fold increase), and CYTH2, significantly downregulated 2.57-fold by IAV pdm09 (p = 0.005), but not significantly dysregulated by either CoV OC43 or RSV. Similarly, some proteins were only significantly affected by CoV OC43, such as RING finger protein 24 (RNF24; upregulated 2.05-fold, p = 2.5 × 10-4) and glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAM; downregulated 4.37-fold, p = 1.8 × 10-5). Several more proteins were significantly affected by RSV, as reflected by numbers in Table 1. These differences in protein alterations also led to predicted differences in cellular networks and canonical pathways (Figures 5, 6, 7, 8, and 9). For example, many, but not all, of the downstream proteins identified by IPA in the Interferon signaling canonical pathway were similarly increased/activated (orange/red colors) (Figure 8). In addition, B-cell lymphoma 2 (BCL2) and v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA) were similarly predicted to be inhibited (blue color). Upstream molecules were differentially affected, with Janus kinase 1 (JAK1) increased more by CoV OC43 than by IAV pdm09 and not affected by RSV. JAK2 also was unaffected by RSV but was increased by both CoV OC43 and IAV pdm09. There also were significant differences in RNA Pol II transcription pathway members (Figure S2), with CoV having little effect on any and IAV activating intron-less pre-mRNA cleavage complex (upper right), TFIID (left) and others and inhibiting the arrested processive elongation complex and other associated complexes (upper right corner). RSV had an overall opposite effect on this pathway than IAV pdm09, inhibiting intron-less pre-mRNA cleavage complex (upper right), TFIID (left) and others and activating the arrested processive elongation complex and other associated complexes (upper right corner) (Figure S2). IPA-predicted Interferon signaling canonical pathway Proteins and their quantities were uploaded into IPA and default canonical pathway settings were used. Protein dysregulations are up (red) or down (green), predicted activation indicated by orange, and predicted inhibition indicated by blue. IPA-predicted necroptosis signaling canonical pathway (A) The necroptosis signaling pathway without Benjamini-Hochberg multiple correction. (B) The same pathway under Benjamini-Hochberg stringency. Protein dysregulations are up (red) or down (green), predicted activation indicated by orange, and predicted inhibition indicated by blue. Proteins and their quantities were uploaded into IPA and default canonical pathway settings were used. Necroptosis plays an important role in RSV disease pathogenesis, and we showed that either genetic deficiency or pharmacological blockade of necroptosis impaired RSV replication and protected from RSV-induced lung injury.33 We found that the IPA-predicted necroptosis signaling pathway also was differentially affected by these three viruses (Figure 9). Although all viruses affected various proteins within this pathway, they did so to different extents. TNFSF10 (TNF superfamily member 10) appeared to only significantly increase plasma membrane receptors TNFRSF10A (tumor necrosis factor receptor superfamily member 10A), also known as TRAIL receptor 1 (TRAIL-R1) or Death receptor 4 (DR4) and tumor necrosis factor receptor superfamily member 10B (TNFRSF10B), also known as TRAIL-R2 or DR5, in CoV OC43-infected A549 cells but not in IAV pdm09- or RSV-infected cells. FASLG (FAS ligand) appeared to only significantly increase the plasma membrane receptor tumor necrosis factor receptor superfamily member 6 (FAS) in RSV-infected A549 cells but not in CoV OC43- or IAV pdm09-infected cells. None of these receptors were affected in IAV pdm09-infected cells. These interactions led to multiple downstream differences in the necroptosis pathway, including in JAK1 (significantly increased by CoV OC43, but not significantly affected by IAV pdm09 or by RSV), signal transducer and activator of transcription 1-alpha/beta (STAT1; slightly decreased by OC43, unaffected by IAV pdm09, and significantly increased by RSV), caspase-4 (CASP4) and protein kinase R (EIF2AK2/PKR), both unaffected by CoV OC43 and by IAV pdm09, but both significantly increased by RSV. These collectively led to differences in tumor protein p53 (TP53; significantly decreased by CoV OC43, significantly increased by IAV pdm09, and, although not detected in RSV-infected cells by us herein, predicted in the pathway to be slightly increased), and the Nalp3/Asc/Casp1 inflammasome (predicted to be activated by CoV OC43 and by RSV but inhibited by IAV pdm09). Collectively, the differences in both numbers of dysregulated proteins affected by each virus, with RSV affecting more proteins irrespective of the fold-change cut-off or p values applied, and the observation that many similarly affected proteins were more greatly affected by RSV than by the other viruses under our experimental conditions, strongly suggest that RSV has a significantly greater impact on the cellular proteome than do either CoV OC43 or IAV pdm09. The results presented here improve our understanding of the proteomic profile of human lung epithelial cells infected by three seasonal respiratory viruses that have a significant impact on healthcare systems worldwide and may have implications for the development of novel therapeutic strategies against these viruses. Limitations of the study To attempt to keep as many variables as constant as possible, we infected a common cell type with the three viruses under study. It is possible that A549 cells respond slightly differently to the viruses. There may be differences in infection kinetics, as suggested by different rates of fluorescent labeling in Figure 1A. Nevertheless, most cells show infection by 24 h, the time at which proteomic samples were harvested. The stochastic nature of proteomic studies and limitations in how many peptides can be sampled by the mass spectrometer is a common limitation in such studies and generally allows sampling of <10% of the cellular genome/proteome. This study examined alterations in quantities of various cellular proteins; therefore, the functional consequences of these changes could not be measured under our conditions. Proteomic results were obtained from A549 cells, a transformed cell type, and results likely would differ in primary cells and in in vivo models. Resource availability Lead contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Barbara N. Porto (barbara.porto@umanitoba.ca). Materials availability This study did not generate new unique reagents. Data and code availability •Raw mass spectrometry data have been deposited under accession no. MSV000102788 at the University of California, San Diego Center for Computational Mass Spectrometry’s MassIVE repository (massive.ucsd.edu). Raw mass spectrometry data have been deposited under accession no. MSV000102788 at the University of California, San Diego Center for Computational Mass Spectrometry’s MassIVE repository (massive.ucsd.edu). •This paper does not report any original code. This paper does not report any original code. •All data reported in this paper will be shared by the lead contact upon request. All data reported in this paper will be shared by the lead contact upon request. •Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. Acknowledgments This study was supported by funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) (grant no. RGPIN-2023-04312) and University of Manitoba Start-Up Funds (grant no. 324636) to B.N.P. and a Canadian Institutes of Health Research Operating Grant (grant no. VR3-172641) to K.M.C. J.A.C. was supported by a University of Manitoba Graduate Fellowship. Author contributions Conceptualization, B.N.P., K.M.C., and J.A.C.; methodology, J.A.C. and K.M.C.; investigation, J.A.C., K.M.C., M.I.R.M., and R.P.Z.; resources, B.N.P. and K.M.C.; writing – original draft, J.A.C. and K.M.C.; writing – review and editing, J.A.C., K.M.C., B.N.P., M.I.R.M., and R.P.Z.; supervision, B.N.P. and K.M.C.; funding acquisition, B.N.P. and K.M.C. Declaration of interests The authors declare that they have no competing interests. STAR★Methods Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesGSDMD Recombinant Rabbit Monoclonal Antibody (PD00-18)Thermo Fisher ScientificRRID:AB_2931124Gasdermin E AntibodyCell Signaling Technology#84005MLKL (D2I6N) Rabbit Monoclonal AntibodyCell Signaling Technology#14993ASC/TMS1 (E1E3I) Rabbit Monoclonal AntibodyCell Signaling Technology13833GAPDH Polyclonal AntibodyThermo Fisher ScientificRRID:AB_2107311Goat anti-rabbit IgG (H + L) Secondary Antibody, HRPThermo Fisher ScientificRRID:AB_1185567Mouse Anti-Influenza A Virus Nucleoprotein Monoclonal Antibody, Unconjugated, Clone AA5HAbcamRRID:AB_445525Anti-Coronavirus Group Antigen, nucleoprotein of OC-43, 229E strain, clone 542-7DMilliporeRRID:AB_95425Anti-Respiratory Syncytial VirusMilliporeRRID:AB_90477Goat anti-Mouse IgG, IgM (H + L) Secondary Antibody, Alexa Fluor™ 488Thermo Fisher ScientificRRID:AB_2534062Donkey anti-Goat IgG (H + L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor™ Plus 647Thermo Fisher ScientificRRID:AB_2762840Bacterial and virus strainsHuman coronavirus OC-43ATCCVR-1558Influenza A virus (IAV) strain A/California/07/2009(H1N1; pdm09)ATCCVR-1805Human respiratory syncytial virusATCCVR-1540Deposited dataRaw mass spectrometry dataThis paperMassIVE MSV000102788Experimental models: Cell linesA549ATCCCCL-185Canine MDCKATCCCCL-34HEp-2ATCCCCL-23Human lung MRC-5ATCCCCL-171Software and algorithmsIngenuity Pathway Analysis (IPA)QiagenN/APrism 10GraphPad SoftwareN/A Experimental model and study participant details Cell lines and virus preparation The human adenocarcinoma alveolar epithelial cell line (A549; ATCC CCL-185) was grown in high-glucose-DMEM supplemented with 10% (v/v) FBS (Gibco; Cat #10437028), 1× l-glutamine, 1× sodium pyruvate, and 1× non-essential amino acids. Canine MDCK cells (ATCC CCL-34) were cultured in the same media but supplemented with 5% FBS instead of 10%. Human lung MRC-5 cells (ATCC CCL-171) were maintained in Eagle’s medium (EMEM; ATCC 30-2003) supplemented with 10% FBS. Cells were maintained at 37 °C in 5% CO2 and were trypsinized and sub-cultured at 1:4 – 1:6 ratios 3 times a week. All cell lines were tested for mycoplasma contamination but were not authenticated. Human coronavirus OC-43 stocks were propagated and titrated in MRC-5 cells. Cells were washed 2× in DMEM lacking FBS to remove serum and infected with OC-43 at a multiplicity of infection (MOI) of 0.001 plaque forming units (PFU) per cell. After 1h adsorption in a 33.5 °C incubator with periodic rocking, infected cells were overlaid with DMEM supplemented with 1× l-glutamine, 1× non-essential amino acids, 1× sodium pyruvate, 0.25% BSA and 1 μg/ml trypsin. Cells were incubated at 33.5 °C and ¾ of the media were replaced two days post-infection (2dpi). Incubation continued until the cells showed >50% cytopathic effect. Supernatants were harvested and clarified of cell debris by centrifugation at 1000×g for 15’. In some cases, virus was concentrated by centrifuging infected culture supernatants at 45,000×g for 2h in a Beckman JA-25.50 rotor and resuspended in small volumes of PBS. Virus titers were determined by immuno-focus assay as described.42 Briefly, 50 μL aliquots of 1:10 dilutions were added to MRC-5 monolayers in 48-well plates. After 1h adsorption in a 33.5 °C incubator with periodic rocking, infected cells were overlaid with 1% Avicel® in 1× Medium 199 (M199) supplemented with 0.25% BSA and 1 μg/ml trypsin. Overlaid cells were incubated at 33.5 °C for 38 – 40h, washed 1× with PBS and fixed in PBS + 3% formaldehyde. After fixation for > 6h, cells were gently lysed with 0.1% NP-40, blocked overnight in TBST + either 0.3% BSA or 5% skim milk, and probed with mouse α-OC-43 N protein antibody (SigmaAldrich #MAB9013). Immune complexes were detected with an HRP-conjugated α-mouse 2° antibody (Cell Signaling #7076) and TrueBlue® (KPL #5510-0030) peroxidase substrate. Influenza A virus (IAV) strain A/California/07/2009(H1N1; pdm09) was propagated and titrated in MDCK cells as described.17 RSV strain A2 was propagated and titrated in HEp-2 cells as described.33 IAV and RSV virus stocks were concentrated by centrifugation and were resuspended in small volumes of PBS as described above for OC43. Method details Virus infection For proteomic analyses, A549 cells (1.8x106/dish) were seeded into 60 mm culture dishes overnight and then were infected with each virus at an MOI of 3 PFU per cell to ensure > 95% synchronous infection according to Poisson calculations. Virus was allowed to adsorb for 2hr and then all culture dishes overlaid with A549 DMEM 5% FBS media. Mock (non-infected A549 cells) and parallel virus-infected cells were harvested at 24 hours post-infection (hpi) and proteomic analyses were performed on cell lysates obtained from three separate biological replicates. The separate biological replicates were set up and harvested on different days. Immunofluorescent confirmation of infection A549 cells (2 × 104 per well) were seeded into black-sided 96-well plates and grown overnight to ∼ 80% confluency. Sets of four replicates each were infected with CoV OC43, IAV pdm09, or RSV A2 at MOI = 3 and incubated for 2 hours (= 0-time adsorption), 12, 24 and 36 hours. Another replicate of each was mock infected with media only and processed at the same time as the 0-hour samples. At specified times, the OC43 and pdm09 samples were washed twice with PBS, fixed with 10% formalin, and stored at 4 °C until staining. Cells were permeabilized with 0.5% Triton X-100 in PBS for 10 minutes and washed once with 0.1% Triton X-100 in PBS, and twice with 0.05% Tween in PBS. The cells were then blocked for 30 minutes with PBS + 10% FBS with agitation. Cells were incubated with Mouse Anti-Influenza A Virus Nucleoprotein (1:800), or Anti-Coronavirus OC43 nucleoprotein (1:750), overnight at room temperature (RT) with agitation. The next day, the cells were washed as above, and secondary antibody was added: Goat anti-Mouse IgG, Alexa Fluor 488 (0.2 μg/ml), for 1 hour at RT. The cells were washed as before and counterstained with Hoechst 33342 (0.1 μg/ml) for 10 min after two washes in PBS. The RSV samples were washed twice with PBS, fixed with methanol and stored at -20 °C until staining. Cells were washed twice with cold PBS and blocked for one hour with TRIS TBS, 10% FBS and 0.05% Triton X-100 at 4 °C with agitation. They were then incubated with Anti-Respiratory Syncytial Virus (1:480) in TRIS TBS 0.05% Triton X-100 overnight at 4 °C with agitation. The next day, cells were washed twice in cold TRIS TBS 0.05% Triton X-100, and secondary antibodies were added: Donkey anti-Goat IgG, Alexa Fluor Plus 647 (5 μg/ml) in TRIS TBS 0.05% Triton X-100 for 1 hour at RT. The cells were washed as above and counterstained with Hoechst 33342 (0.1 μg/ml) for 10 min. After three washes in TRIS TBS 0.05% Triton X-100, PBS was added to the cells. Immunofluorescence was observed using the Cytation 10 microscope at 4× magnification (Agilent Technologies). Protein quantification and quantitative mass spectrometry Mock non-infected and parallel infected cells were scrapped from the monolayers and washed 3 times with PBS. Cell pellets were lysed in 4% SDS, 100 mM TRIS, pH 8.5 using a probe sonicator. Cleared supernatants were used to determine protein concentrations (Thermo Scientific PierceTM Detergent Compatible Bradford Assay Kit). Disulfide bonds were reduced with 10 mM DTT for 30 min and free Cys residues were alkylated by incubating with 50 mM iodoacetamide at 57°C for 45 min in the dark and at room temperature. For each sample, 40 μg of total protein was processed using single-pot solid-phase-enhanced sample preparation (SP3).43 A total of 160 μg of a 1:1 (v/v) mix of two types of carboxylate-modified SeraMag Speed beads (GE Life Sciences) was added to each sample, HEPES was used to adjust to pH 7.0, and acetonitrile (ACN) was added to a final concentration of 70% (v/v). Samples were incubated at room temperature on a tube rotator for 18 min. Sample tubes were placed on a magnetic rack, and after 1 min the supernatants were discarded, and the pellets were rinsed 2× with 200 μL of 70% ethanol and 1× with 180 μL of 100% ACN. Beads were resuspended in 120 μL of 50 mM TRIS, pH 8.5, supplemented with trypsin (Promega sequencing grade) at an enzyme:protein ratio of 1:25 (w/w). Samples were digested at 37°C for 16 hours, and supernatants were transferred to clean tubes. Next, beads were sonicated in 50 μL of 50 mM TRIS, pH 8.5, and supernatants were combined with their respective tubes from the previous step. Peptide concentrations were determined using Pierce™ Quantitative Fluorometric Peptide Assay (Fisher Scientific). Per sample, 300 ng were analyzed in randomized order by LC-MS/MS using an EvoSep One equipped with an EvoSep EV1137 column in 15-samples-per-day mode, online-coupled to a TimsTOF Pro2 operating in DIA-PASEF (data independent acquisition-parallel accumulation-serial fragmentation) mode. The DIA-PASEF method was optimized using py_diAID over a range from m/z 350.2 to 1493.2.44 Each DIA-PASEF scan used variable isolation window widths that were split along two ion mobility ranges adjusted based on precursor intensity. One DIA-PASEF cycle consisted of 17 scans, and the cycle time was 1.91 s. The ion mobility was scanned from 0.7-1.5 Vs/cm2 at a ramp time of 100 ms while ramp and accumulation times were locked to 100% duty cycle. The collision energy was ramped linearly as a function of the mobility from 59 eV at 1/K0 = 1. 6 Vs cm-2 to 20 eV at 1/K0 = 0.6 Vs cm-2. Raw data were analyzed using DIA-NN 1.8.2 in 2-pass mode and an A549 spectral library generated in-house using FragPipe. Only (I) unique proteins that had been quantified with at least 2 unique peptides, and (II) were quantified in at least 2 out of 3 samples of any condition were retained. The proteomic pathway analyses were performed using IPA software to generate top CoV-, IAV- and RSV-induced altered cellular networks, functions and canonical pathways. Western blotting Cell lysates were heated at 94 °C for 10 minutes and subjected to electrophoresis in Bolt 4-12%, Bis-Tris Plus WedgeWell Gels, using MES SDS Running Buffer (Thermo Scientific). The quantified proteins (Pierce BCA Protein Assay Kit, Thermo Scientific) were transferred to nitrocellulose membranes using the iBlot 2 system (Thermo Scientific). Then, the membranes were blocked in StartingBlock (Thermo Scientific) for 1 h at room temperature and incubated overnight with anti-GSDMD (1:2000; Ma5-44666; Invitrogen), anti-GSDME (1:1500; 84005; Cell signaling), anti-GAPDH (1:5000, PA1-987, Invitrogen), anti-MLKL (1:1000; 14993; Cell signaling), or anti-PYCARD (1:1000; 13833; Cell signaling) antibodies, followed by horseradish peroxidase (HRP) anti-rabbit secondary antibody (1:5000; 32460, Thermo Scientific). Protein expression was detected using SuperSignal West Pico Plus (Thermo Scientific), and the membranes were imaged using the MicroChemi 4.2 (DNr Bio Imaging Systems). Quantification and statistical analysis Individual protein differences between non-infected and each infected sample were converted to fold changes and p-values were calculated using student’s T-test for grouped data to determine the level of significance. Z-scores for each replicate across all time points were calculated to classify proteins which were not considered significant by T-test. A p-value of < 0.05 was used to select significantly dysregulated proteins and Z-score values of ≥ +1.96σ and ≤ −1.96σ were considered valid criteria for up- and down-regulation. Only proteins identified by a minimum of two unique peptides, and virus/mock ratios obtained from a minimum of two separate biological replicates, were retained for subsequent analysis. Datasets containing protein IDs, fold changes compared to mock-infected cells, and p-values were uploaded into and analyzed by Ingenuity Pathway Analysis (IPA) software. The IPA database was used to classify all significantly regulated proteins based on protein type and subcellular location. Information regarding the top affected bio-functions, canonical pathways, upstream molecules, and interconnecting networks were exported by performing a core analysis in IPA. Footnotes Supplemental information can be found online at https://doi.org/10.1016/j.isci.2026.117427. Contributor Information Barbara N. Porto, Email: barbara.porto@umanitoba.ca. Kevin M. Coombs, Email: kevin.coombs@umanitoba.ca. Supplemental information Document S1. Figures S1 and S2 and Data S1 Table S1. A549 proteins significantly dysregulated ≥ 3-fold, and p < 0.01, by human coronavirus OC43, influenza virus pdm09 and RSV Table S2. A549 proteins affected by CoV OC43, IAV pdm09, and RSV infection Table S3. IPA-identified networks at fold-change cut-off ±1.50 References Associated Data Supplementary Materials Document S1. Figures S1 and S2 and Data S1 Table S1. A549 proteins significantly dysregulated ≥ 3-fold, and p < 0.01, by human coronavirus OC43, influenza virus pdm09 and RSV Table S2. A549 proteins affected by CoV OC43, IAV pdm09, and RSV infection Table S3. IPA-identified networks at fold-change cut-off ±1.50 Data Availability Statement •Raw mass spectrometry data have been deposited under accession no. MSV000102788 at the University of California, San Diego Center for Computational Mass Spectrometry’s MassIVE repository (massive.ucsd.edu). Raw mass spectrometry data have been deposited under accession no. MSV000102788 at the University of California, San Diego Center for Computational Mass Spectrometry’s MassIVE repository (massive.ucsd.edu). •This paper does not report any original code. This paper does not report any original code. •All data reported in this paper will be shared by the lead contact upon request. All data reported in this paper will be shared by the lead contact upon request. •Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.